தேசிய நிறுவனம் ஆஃப் ஆரோக்கியம் பக்கவாதம் அளவு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தேசிய நிறுவனம் ஆஃப் ஆரோக்கியம் பக்கவாதம் அளவு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தேசிய நிறுவனம் ஆஃப் ஆரோக்கியம் பக்கவாதம் அளவு Today - Breaking & Trending Today

Biogen Inc.: Biogen Announces Exercise of Option to Acquire the Investigational Drug TMS-007 for Acute Ischemic Stroke Based on Positive Phase 2a Data


(0)
TMS-007 has the potential to be a next generation thrombolytic with an improved benefit-risk profile
Acute ischemic stroke is caused by a blockage of blood supply to the brain, and current thrombolytics are limited in use due in part to increased risks of bleeding
Phase 2a study demonstrated positive impacts on blood vessel reopening and patient functional recovery with no incidence of symptomatic intracranial hemorrhage
Biogen to make a one-time payment of $18 million and may pay potential milestone payments and royalties to TMS Co., Ltd.
CAMBRIDGE, Mass. and FUCHU-SHI, Tokyo, May 12, 2021Inc (Nasdaq: BIIB) and TMS Co., Ltd. announced today that Biogen exercised its option to acquire TMS-007, an investigational drug for acute ischemic stroke, from TMS. Biogen s decision to acquire TMS-007 was based on positive data from a Phase 2a study. The study met its primary safety objective with no incidence of symptomatic intracranial hemorrhage (sICH) and demonst ....

United Kingdom , United States , Fuchu Shi , David Caouette , Mike Hencke , Walter Gilbert , Charles Weissmann , Heinz Schaller , Kenneth Murray , Alfred Sandrock Jr , Co Ltd , American Heart Association , Professor Of The University , Inc Nasdaq , National Institute Of Health Stroke Scale , Exchange Commission , Alfred Sandrock , American Heart , Plasminogen Activator , National Institute , Health Stroke Scale , Rankin Scale , About Acute Ischemic , Nobel Prize , Today Biogen , Chief Scientist ,